FRA:FRE Fresenius SE & Co. KGaA (FRE) Stock Price, News & Analysis €31.86 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range€31.59▼€32.0650-Day Range€27.52▼€31.4652-Week Range€60.16▼€80.00Volume913,229 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Fresenius SE & Co. KGaA alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Fresenius SE & Co. KGaA Stock (FRA:FRE)Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.Read More FRE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FRE Stock News HeadlinesJuly 19, 2024 | markets.businessinsider.comDeutsche Numis Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)May 27, 2024 | msn.comCompare with FTSE Fresenius SE & Co KGaA Index (SSFREG)July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 23, 2024 | finance.yahoo.comInvestors five-year losses continue as Fresenius SE KGaA (ETR:FRE) dips a further 3.8% this week, earnings continue to declineMay 8, 2024 | marketwatch.comFresenius Shares Rise After Guidance Lift, Vamed ExitMay 7, 2024 | markets.businessinsider.comEQS-News: STRABAG expands service portfolio in technical facility management with acquisition of parts of VAMEDMay 7, 2024 | bloomberg.comFresenius Said to Plan Elimination of Vamed in Streamlining StepMay 2, 2024 | marketwatch.comFresenius to Sell Vamed's Rehabilitation Business to PAI PartnersJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 2, 2024 | bloomberg.comFresenius Sells Controlling Stake in Vamed Rehab Business to PAIApril 30, 2024 | finance.yahoo.comInstitutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the companyApril 29, 2024 | finance.yahoo.comGlobal Drug Infusion System Market Size Grows Steadily at a CAGR of 6.9%: Straits ResearchApril 13, 2024 | finanznachrichten.deApheresis Market Worth $3.9 billion | MarketsandMarketsMarch 27, 2024 | uk.finance.yahoo.comGlobal Local Anesthesia Drugs Market Forecast Reveals High Demand and Expansion by 2029February 29, 2024 | barrons.comFresenius SE & Co. KGaAFebruary 28, 2024 | seekingalpha.comFresenius SE: Hoping For The Turnaround In 2024February 22, 2024 | marketwatch.comU.S. Futures Fall, European Stocks MixedFebruary 21, 2024 | msn.comHealthcare group Fresenius tops Q4 operating profit forecastSee More Headlines Receive FRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeFRA SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolFRA:FRE CUSIPN/A CIKN/A Webwww.fresenius.de Phone+49-6172-6080FaxN/AEmployees190,863Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Michael Sen (Age 56)CEO, President & Chairman of Management Board - Fresenius Management SE Comp: $4.09MMs. Sara Lisa Hennicken (Age 44)CFO & Member of the Management Board - Fresenius Management SE Comp: $1.55MMr. Pierluigi AntonelliMember of Management Board of Fresenius Management SE & CEO of Fresenius KabiDr. Michael Sven Moser Ph.D. (Age 46)Member of Management Board of Fresenius Management SE Comp: $1.2MMr. Robert Moller (Age 53)Member of the Management Board of Fresenius Management SE Comp: $1.15MMr. Markus GeorgiSenior Vice President of Investor RelationsMatthias LinkSenior Vice President Corporate CommunicationsMore ExecutivesKey CompetitorsFresenius Medical CareETR:FMERHÖN-KLINIKUM AktiengesellschaftETR:RHKEssilor International Société AnonymeEPA:EIFielmann GroupFRA:FIEGenfitEPA:GNFTView All Competitors FRE Stock Analysis - Frequently Asked Questions How have FRE shares performed this year? Fresenius SE & Co. KGaA's stock was trading at €28.07 on January 1st, 2024. Since then, FRE shares have increased by 13.5% and is now trading at €31.86. View the best growth stocks for 2024 here. What other stocks do shareholders of Fresenius SE & Co. KGaA own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius SE & Co. KGaA investors own include Illumina (ILMN), Daimler (DAI), Endologix (ELGX), Allianz (ALV), Cambrex (CBM) and Linde (LIN). This page (FRA:FRE) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius SE & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius SE & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.